S100A12 decreased SAA-induced ERK1/2 and MEK1/2 phosphorylation. by Yuen Ming Chung (406571)

Lumcorin decreases melanoma growth. by Katarzyna Pietraszek (113579)

Overexpression of PR decreases Myc expression and activity. by Tamar Kavlashvili (849072)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

S100A7-downregulation decreases angiogenesis. by Vikram Paruchuri (87721)

miR-100 decreases tumor size. by Bahauddeen M. Alrfaei (484859)

RA increases S100β+ and decreases peripherin+ cell prevalence while EDN3 decreases S100β+ cell prevalence. by Jonathan M. Gisser (456149)

“…(A) The proportion of S100β+ cells was enriched by RA and decreased in response to EDN3 (B) RA increased, and EDN3 decreased the fraction of proliferating S100β+ cells. …”

Endotoxin tolerance is associated with decreased TNFα and increased IL-10, S100A8 and S100A9 mRNA expressions. by Mathieu Fontaine (582183)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”

TUDCA decreases ER stress in HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

“…<p>(<b>A</b>) The expression levels of ER stress markers (P-PERK 0.6±0.1-fold, p<0.001, n = 5; PERK 0.7±0.1-fold, p = 0.00364, n = 5; P-IRE1α 0.6±0.0-fold, p<0.001, n = 5; IRE1α 0.6±0.1-fold, p<0.001, n = 5; GRP78 0.8±0.1-fold, p<0.001, n = 5; cleaved ATF6 0.1±0.0-fold, p<0.001, n = 5; spliced XBP1 0.3±0.0-fold, p<0.001, n = 5; 2 males and 3 females) are all decreased while the N-glycosylated VEGFR2 is increased (3.5±0.2-fold, p<0.001, n = 5) in HOX neonatal lungs at P10 indicating TUDCA can attenuate hyperoxia-induced ER stress. …”

ANG II treatment leads to decreased contractile function. by Renita E. Horton (847891)

“…(E) Representative stress traces generated from x-projections of films (F) ANG II treatment leads to a decrease in contractile stress generation. Control n = 85 tissues, 5 nM n = 15 tissues, 100 nM n = 69 tissues, 3 harvests. …”

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

Overexpression of Diva decreases apoptosis and mitochondrial membrane disruption. by Nicole Suyun Liu (311271)

Decreased mitochondrial reactive oxygen species in Aβ resistant cells. by Jordan T. Newington (223389)

“…Conversely, mitochondrial ROS significantly increased in the parental line when exposed to Aβ (**, P<0.05). <b>B</b>) The B12 resistant lines, R2 and R4 also exhibited decreased mitochondrial ROS when compared to parental cells under similar conditions (*, P<0.01). …”

MiR-138 decreases S100A1 gene expression in Endothelial Cells. by Anagha Sen (482673)

Subjects:

Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

Decreased survival of HL60 cells after fractionated irradiation. by Annette Geltmeier (779536)

Overexpression of ZnT3 and ZnT10 decreases ROS and prevents Ang II-induced senescence. by Nikolay Patrushev (179006)

Subjects:

The decrease in the correlation between DNM density and divergence with increasing evolutionary divergence. by Thomas C. A. Smith (5028620)